ApTOLL, a neuroprotective agent, has shown promising results in the APRIL 1b/2a trial and reduced death and disability when used alongside standard...

Rapid ICH 3.0 and Rapid Hyperdensity represent the best-in-class hemorrhagic solutions supporting clinicians managing intracranial hemorrhage (both...

Based on current evidence, treatment with intravenous alteplase is recommended for patients with DWI-FLAIR mismatch or perfusion mismatch on CT or...

Pivotal trials helped establish the role of endovascular thrombectomy (EVT) treatment for selected ischemic stroke patients with large vessel...